Medtronic plc, a global leader in healthcare technology, today announced it has received CE Mark for the LigaSure™ RAS vessel-sealing technology, expanding Hugo™ robotic-assisted surgery (RAS) system capabilities for gynecologic, general, and urologic procedures in Europe.

美敦力公司（Medtronic plc），作为全球医疗技术的领导者，今天宣布其LigaSure™ RAS血管封闭技术已获得CE认证，这将扩展Hugo™机器人辅助手术（RAS）系统在欧洲的妇科、普通外科和泌尿外科手术中的能力。

As the first-ever robotic-driven LigaSure™ instrument, this milestone represents the beginning of a new era for the vessel-sealing technology that has been used in more than 35 million procedures across 65+ countries over the last two decades.

作为首个由机器人驱动的LigaSure™仪器，这一里程碑标志着血管密封技术新时代的开始。在过去的二十年里，该技术已在65多个国家的超过3500万例手术中得到应用。

“Today, with CE Mark for LigaSure™ RAS, Medtronic is fulfilling a promise to customers to integrate our trusted vessel-sealing technology onto the Hugo™ RAS system,” said Matt Anderson, senior vice president and president of the Surgical business, which is part of the Medical Surgical Portfolio at Medtronic.

“今天，随着LigaSure™ RAS获得CE认证，美敦力正在兑现对客户的承诺，将我们值得信赖的血管密封技术整合到Hugo™ RAS系统中，”美敦力外科业务高级副总裁兼总裁、隶属于美敦力医疗外科产品组合的马特·安德森表示。

“More than fulfilling a commitment, this regulatory approval is a big step forward as we continue to shape the future of surgery with surgical teams who share our passion and commitment to deliver the best possible care to every patient.”.

“这一监管批准不仅是履行承诺，更是向前迈出的一大步，因为我们继续与同样充满热情并致力于为每位患者提供最佳护理的外科团队携手塑造手术的未来。”

Dr. Miguel Caceres of Pacifica Salud Hospital in Panama was one of the first surgeons in the world to use LigaSure™ RAS with the Hugo™ RAS system.

巴拿马太平洋萨鲁德医院的米格尔·卡塞雷斯博士是世界上最早使用 LigaSure™ RAS 和 Hugo™ RAS 系统的外科医生之一。

“LigaSure™ technology is one of the most important advances for minimally invasive surgery because it provides sealing and cutting in a way that is very, very secure for the performance of the surgeon and the security of the patient,” said Dr. Caceres. “As a robotic surgeon, we want LigaSure™ technology because it gives us confidence in the security of the seal.

“LigaSure™ 技术是微创手术领域最重要的进步之一，因为它能够以非常、非常安全的方式进行密封和切割，确保了外科医生的操作效果和患者的安全，”卡塞雷斯博士说道。“作为一名机器人外科医生，我们希望使用 LigaSure™ 技术，因为它让我们对密封的安全性充满信心。”

We are already seeing the benefits in our cases with the Hugo™ RAS system.”.

我们已经在使用 Hugo™ RAS 系统的案例中看到了好处。

Powered by the Valleylab™ FT10 energy platform and for use exclusively with the Hugo™ RAS system, the LigaSure™ RAS Maryland instrument is indicated for sealing and cutting vessels, thick tissue, and lymphatics up to and including 7 mm in diameter. The device reliably seals vessels in approximately 2 seconds while minimizing thermal spread to surrounding tissue..

LigaSure™ RAS Maryland器械由Valleylab™ FT10能量平台提供动力，并且专为配合Hugo™ RAS系统使用而设计，适用于密封和切割直径达7毫米及以下的血管、厚组织和淋巴管。该设备能够在约2秒内可靠地密封血管，同时最大限度地减少对周围组织的热扩散。

This week at SRS: LigaSure™ RAS initial experience, Hugo™ GYN data and telesurgery demo

本周在SRS：LigaSure™ RAS初步体验，Hugo™ GYN数据和远程手术演示

Dr. Caceres, who has been using the Hugo™ RAS system four years, will discuss his initial experience with LigaSure™ RAS during a Medtronic-sponsored symposium at the Society of Robotic Surgery (SRS) 2025 Annual Meeting, July 16-20 in Strasbourg, France.

卡塞雷斯博士在过去的四年中一直使用Hugo™ RAS系统，他将在2025年7月16日至20日于法国斯特拉斯堡举行的机器人外科学会（SRS）年度会议期间，在美敦力公司赞助的研讨会上讨论他对LigaSure™ RAS的初步体验。

SRS also includes a presentation on preliminary outcomes of hysterectomy for benign gynecologic conditions — a Medtronic-sponsored study of 112 Hugo™ RAS procedures across eight sites in Europe and Asia. Dr. Francesco Fanfani, associate professor at Agostino Gemelli University Polyclinic, will present the data..

SRS 还包括一项关于良性妇科疾病子宫切除术初步结果的报告 —— 这是一项由美敦力公司赞助的研究，涵盖了欧洲和亚洲八个地点的 112 例 Hugo™ RAS 手术。Agostino Gemelli 大学综合医院副教授 Francesco Fanfani 博士将展示这些数据。

Looking ahead to the next frontier of surgery, Medtronic will demo telesurgery capabilities on the Hugo™ RAS system from the nearby IRCAD facility — one of its strategic training partners. The demo will be followed by a panel discussion, including authors of Technical Guidelines for Remote Robotic-Assisted Surgery, which was recently published in the .

展望手术的下一个前沿领域，美敦力将与附近的IRCAD机构合作展示Hugo™ RAS系统的远程手术能力，该机构是其战略培训合作伙伴之一。随后将举行专题讨论会，参与者包括最近发布的《远程机器人辅助手术技术指南》的作者们。

Journal of World Surgery

世界外科杂志

.

。

The paper is a foundational piece to support safe and scalable telesurgery, reinforcing Medtronic’s commitment to innovation powered by human connection.

这篇论文是支持安全且可扩展的远程手术的基础之作，进一步巩固了美敦力公司以人为本的创新承诺。

These announcements come amid growing momentum for the Hugo™ RAS system, which is now in use across 30+ countries on five continents, with over 270 independent publications supporting its clinical use across urology, gynecology, and general surgery procedures.

这些公告发布的背景是 Hugo™ RAS 系统的势头日益强劲，该系统目前已在五大洲的 30 多个国家投入使用，并有 270 多篇独立出版物支持其在泌尿科、妇科和普通外科手术中的临床应用。

In the U.S., the company’s submission for a urology indication is under review by the Food and Drug Administration, with an expected U.S. entrance later in the company’s current fiscal year, followed by planned indication expansions into hernia and gynecology.

在美国，该公司针对泌尿科适应症的申请正在接受食品药品监督管理局的审查，预计将在公司当前财政年度晚些时候进入美国市场，随后计划将适应症扩展到疝气和妇科领域。

The Medtronic Hugo™ RAS system is commercially available in certain geographies. Regulatory requirements of individual countries and regions will determine approval, clearance, or market availability. In the EU, the Hugo™ RAS system is CE marked. In the U.S., the Hugo™ RAS system is an investigational device not for sale..

美敦力Hugo™ RAS系统在某些地区已上市。各个国家和地区的监管要求将决定其批准、许可或市场可用性。在欧盟，Hugo™ RAS系统已获得CE标志。在美国，Hugo™ RAS系统属于研究用设备，尚未上市销售。

About Medtronic

美敦力公司简介

Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries.

大胆思考。更大胆的行动。我们是美敦力。美敦力公司总部位于爱尔兰戈尔韦，是全球领先的医疗技术公司，通过寻找和发现解决方案，大胆攻克人类面临的最严峻健康问题。我们的使命——减轻病痛、恢复健康、延长生命——团结了遍布150多个国家的95,000多名充满热情的员工。

Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day.

我们的技术和疗法治疗70种健康状况，包括心脏设备、手术机器人、胰岛素泵、手术工具、患者监测系统等。凭借我们多元化的知识、永无止境的好奇心和帮助所有需要帮助的人的愿望，我们提供了创新技术，每秒、每小时、每一天都在改变两个人的生活。

Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit .

随着我们赋能以洞察力为驱动的护理、以人为本的体验以及为我们的世界带来更好的结果，期待我们做得更多。在我们所做的一切中，我们正在创造非凡。欲了解有关美敦力的更多信息，请访问。